ALKY Demonstrates Efficacy in dMGMT-NETs in Pancreatic and Thoracic Cancers
The following is a summary of “Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6 -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET),” published in the November 2024 issue of Oncology by Walter et...